|
|
||||||||
The Journal of Immunology, Vol 158, Issue 12 5658-5667, Copyright © 1997 by American Association of Immunologists
ARTICLES |
Y Lin, M Vandeputte and M Waer
Division of Nephrology, University of Leuven, Belgium.
Hyperacute, complement-mediated xenograft (Xg) rejection is a first major hurdle for xenotransplantation. Thereafter, cellular immunity, including T and B lymphocytes, NK cells, and macrophages may become involved as well. In the present study, hamster heart Xgs were performed in Leflunomide (LF)-treated nude rats. These animals, which are genetically T cell deficient, are known to have a strong NK activity. Moreover, xenoantibody (XAb) formation by B lymphocytes was previously shown to be blocked in nude rats by LF. Hence, this model was well suited to study the role of NK cells and macrophages in Xg rejection. Despite a total suppression of XAb formation, LF-treated nude rats rejected hamster heart Xgs at a same speed (3 days) as untreated nude rats. NK cells played a major role in this rejection process. Indeed, an NK cell-dominated cellular infiltration was noticed in the rejected Xgs and the addition of an anti-NK cell serum, anti- Asialo GM-1 (ASGM-1), to the LF treatment resulted in a significant delay of Xg rejection (from 3 days to 6 days; p < 0.0001) that seemed to be mediated by activated macrophages because 1) spleens from rejecting animals showed an increased percentage of macrophages (ED1+ or ED2+) and 2) rejected Xgs were infiltrated predominantly by macrophages. Moreover, splenocytes taken from rats that rejected Xgs despite a treatment with LF + ASGM-1 provoked an acceleration of Xg rejection when transferred to newly transplanted LF + ASGM-1-treated nude rats, and finally, the latter accelerating effect disappeared when macrophages were first depleted from the adoptively transferred splenocytes. This study thus shows that NK cells and macrophages can be activated in the absence of T cells or XAbs to directly reject Xgs.
This article has been cited by other articles:
![]() |
B. G. Lilienfeld, C. Garcia-Borges, M. D. Crew, and J. D. Seebach Porcine UL16-Binding Protein 1 Expressed on the Surface of Endothelial Cells Triggers Human NK Cytotoxicity through NKG2D J. Immunol., August 15, 2006; 177(4): 2146 - 2152. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Forte, B. G. Lilienfeld, B. C. Baumann, and J. D. Seebach Human NK Cytotoxicity against Porcine Cells Is Triggered by NKp44 and NKG2D J. Immunol., October 15, 2005; 175(8): 5463 - 5470. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Peterson, R. Jin, S. Hyduk, P. Duchesneau, M. I. Cybulsky, and T. K. Waddell Monocyte Adhesion to Xenogeneic Endothelium during Laminar Flow Is Dependent on {alpha}-Gal-Mediated Monocyte Activation J. Immunol., June 15, 2005; 174(12): 8072 - 8081. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Gordon, L. S. Wicker, L. B. Peterson, D. V. Serreze, T. G. Markees, L. D. Shultz, A. A. Rossini, D. L. Greiner, and J. P. Mordes Autoimmune Diabetes and Resistance to Xenograft Transplantation Tolerance in NOD Mice Diabetes, January 1, 2005; 54(1): 107 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyagawa, T. Kubo, K. Matsunami, T. Kusama, K. Beppu, H. Nozaki, T. Moritan, C. Ahn, J. Y. Kim, D. Fukuta, et al. Delta-Short Consensus Repeat 4-Decay Accelerating Factor (DAF: CD55) Inhibits Complement-Mediated Cytolysis but Not NK Cell-Mediated Cytolysis J. Immunol., September 15, 2004; 173(6): 3945 - 3952. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yi, W. J. Hawthorne, A. M. Lehnert, H. Ha, J. K. W. Wong, N. van Rooijen, K. Davey, A. T. Patel, S. N. Walters, A. Chandra, et al. T Cell-Activated Macrophages Are Capable of Both Recognition and Rejection of Pancreatic Islet Xenografts J. Immunol., March 1, 2003; 170(5): 2750 - 2758. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. E. Holzknecht, K. L. Kuypers, T. B. Plummer, J. Williams, M. Bustos, G. J. Gores, G. J. Brunn, and J. L. Platt Apoptosis and Cellular Activation in the Pathogenesis of Acute Vascular Rejection Circ. Res., December 13, 2002; 91(12): 1135 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Costa, D. F. Barber, and W. L. Fodor Human NK Cell-Mediated Cytotoxicity Triggered by CD86 and Gal{alpha}1,3-Gal Is Inhibited in Genetically Modified Porcine Cells J. Immunol., April 15, 2002; 168(8): 3808 - 3816. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanaka, K.-h. Sonoda, and J. W. Streilein Acute Rejection of Orthotopic Corneal Xenografts in Mice Depends on CD4+ T Cells and Self-Antigen-Presenting Cells Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2878 - 2884. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsuyuki, J. A. Horvath-Arcidiacono, and E. T. Bloom Effect of Redox Modulation on Xenogeneic Target Cells: The Combination of Nitric Oxide and Thiol Deprivation Protects Porcine Endothelial Cells from Lysis by IL-2-Activated Human NK Cells J. Immunol., March 15, 2001; 166(6): 4106 - 4114. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Xia, J. Goebels, O. Rutgeerts, M. Vandeputte, and M. Waer Transplantation Tolerance and Autoimmunity After Xenogeneic Thymus Transplantation J. Immunol., February 1, 2001; 166(3): 1843 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanaka, J. Yamada, and J. W. Streilein Xenoreactive CD4+ T Cells and Acute Rejection of Orthotopic Guinea Pig Corneas in Mice Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1827 - 1832. [Abstract] [Full Text] |
||||
![]() |
Y. Lin, M. P. Soares, K. Sato, E. Csizmadia, S. C. Robson, N. Smith, and F. H. Bach Long-Term Survival of Hamster Hearts in Presensitized Rats J. Immunol., May 1, 2000; 164(9): 4883 - 4892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Nakamura, C. Naper, E. C. Niemi, S. C. Spusta, B. Rolstad, G. W. Butcher, W. E. Seaman, and J. C. Ryan Natural Killing of Xenogeneic Cells Mediated by the Mouse Ly-49D Receptor J. Immunol., November 1, 1999; 163(9): 4694 - 4700. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brouard, B. Vanhove, K. Gagne, A. Neumann, P. Douillard, A. Moreau, C. Cuturi, and J. P. Soulillou T Cell Repertoire Alterations of Vascularized Xenografts J. Immunol., March 15, 1999; 162(6): 3367 - 3377. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lin, M. P. Soares, K. Sato, K. Takigami, E. Csizmadia, J. Anrather, and F. H. Bach Rejection of Cardiac Xenografts by CD4+ or CD8+ T Cells J. Immunol., January 15, 1999; 162(2): 1206 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. ROSSINI, D. L. GREINER, and J. P. MORDES Induction of Immunologic Tolerance for Transplantation Physiol Rev, January 1, 1999; 79(1): 99 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Idris, K. Iizuka, H. R.C. Smith, A. A. Scalzo, and W. M. Yokoyama Genetic Control Of Natural Killing and In Vivo Tumor Elimination by the Chok Locus J. Exp. Med., December 21, 1998; 188(12): 2243 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyatake, K. Sato, K. Takigami, N. Koyamada, W. W. Hancock, H. Bazin, D. Latinne, F. H. Bach, and M. P. Soares Complement-Fixing Elicited Antibodies Are a Major Component in the Pathogenesis of Xenograft Rejection J. Immunol., April 15, 1998; 160(8): 4114 - 4123. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lin, M. Vandeputte, and M. Waer Accommodation and T-Independent B Cell Tolerance in Rats With Long Term Surviving Hamster Heart Xenografts J. Immunol., January 1, 1998; 160(1): 369 - 375. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |